Communiqués

17/09 Sleep Cycle: Reorganisation trims headcount, targets SEK35m in annual savings AQ
17/09 Sleep Cycle introduces a new way of working and intends to streamline the organisation – savings of approximately SEK 35 million on an annual basis AQ
16/09 University of Cambridge: Sleep app tracks link between air pollution and a bad night's sleep AQ
15/09 Cambridge Study Uses Sleep Cycle's Technology to Link Air Pollution and Nighttime Coughing Worldwide AQ
14/09 Sleep Cycle: Sleep apnea launches in Europe first, US pathway paused AQ
11/09 Sleep Cycle Accelerates European Launch of Sleep Apnea Risk Detection While Preserving Pathway to US Regulatory Clearance AQ
04/09 Sleep Cycle's sleep analysis moves inside the product as partner Moera launches temperature-regulating mattress toppers AQ
03/09 AI Sleep Data Could Provide One-Week Early Warning of Flu and COVID-19 Activity AQ
27/08 Sleep Cycle: Change of CEO, no total surprise given new main owner and board AQ
27/08 Sleep Cycle (Q2 Review):B2B momentum intact, MedTech delayed by enrollment, not engineering AQ
27/08 Sleep Cycle appoints Mikael Kågebäck as acting CEO AQ
26/08 Sleep Cycle Interim Report April - June 2026: A greater opportunity takes shape PU
26/08 Sleep Cycle Interim Report April – June 2026: A greater opportunity takes shape AQ
24/08 Sleep Cycle AB (publ) invites you to a presentation of the second quarter of 2026 AQ
05/08 Resolutions at Sleep Cycle’s Extraordinary General Meeting 2026 AQ
23/07 Sleep Cycle signs tech licensing agreement with Ant Group AQ
20/07 Snark BidCo announces outcome in the extended acceptance period in the offer to Sleep Cycle shareholders AQ
10/07 Notice of Extraordinary General Meeting in Sleep Cycle AB (publ) AQ
03/07 Snark BidCo announces outcome and completes the offer to Sleep Cycle shareholders and thereby becomes owner of 78.2 percent of the shares AQ
03/07 Sleep Cycle signs commercial SDK licensing agreement with Ultrahuman following successful pilot AQ
22/05 The Board of Directors of Sleep Cycle unanimously recommends the shareholders not to accept the public cash offer by Altor AQ
11/05 Sleep Cycle: Withdrawal of fair value range following Altor bid AQ
11/05 The Board of Directors evaluates the offer from Altor AQ
30/04 Sleep Cycle: B2B revenue continues to impress – Q1 review AQ
29/04 Sleep Cycle: Strong revenue from new sources – Q1 initial take AQ
Aucun résultat pour cette recherche
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT